BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
50,000
$46.14
$2,306,950
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
50,000
$41.77
$2,088,300
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
50,000
$39.48
$1,973,800
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
60,000
$38.57
$2,314,200
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
60,000
$37.79
$2,267,280
Option
GOLDSTEIN DOV A MDdirectordirector
Common Stock
13,000
$7.21
$93,730
Option
GOLDSTEIN DOV A MDdirectordirector
Stock Option (right to buy)
5,000
$14.42
$72,100
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
60,000
$38.47
$2,308,440
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
80,000
$38.77
$3,101,760
Purchase
BIOTECH TARGET N V10 percent owner10 percent owner
Common Stock
50,000
$42.24
$2,112,000
Sale
NEWTON ROGER Sdirectordirector
Common Stock
25,000
$71.91
$1,797,750
Sale
NEWTON ROGER Sdirectordirector
Common Stock
15,956
$71.46
$1,140,216
Option
NEWTON ROGER Sdirectordirector
Common Stock
34,651
$6.99
$242,210
Option
NEWTON ROGER Sdirectordirector
Warrant to Purchase Common Stock
34,651
$6.99
$242,210
Showing 50 to 100 of 157 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.